Effect of NF-κB–specific inhibitor CAPE. (A) Analysis of nuclear NF-κB translocation in the eosinophils of CSS patients in the presence or absence of CAPE. (B) Flow cytometry analysis of apoptotic cells in the presence or absence of CAPE. (C) Comparison of annexin V–positive cells in the presence or absence of CAPE. *P < .01 as compared with no stimulation, Bonferroni-Dunn test with 1-way factorial ANOVA). (D) Comparison of GM-CSF production from eosinophils of CSS patients in the presence or absence of CAPE (*P < .01 as compared with no stimulation, Bonferroni-Dunn test with 1-way factorial ANOVA). Error bars indicate standard deviation.